Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

20.0%

2 terminated/withdrawn out of 10 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

10%

1 trials in Phase 3/4

Results Transparency

88%

7 of 8 completed trials have results

Key Signals

7 with results

Enrollment Performance

Analytics

N/A

8(80.0%)

Phase 4

1(10.0%)

Phase 2

1(10.0%)

10Total

N/A(8)

Phase 4(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials

NCT02736799Not ApplicableCompleted

Effect of Vibrant Capsule on Gastric Emptying and Antropyloroduodenal Motility in Healthy Volunteers

Role: lead

NCT03879239Not ApplicableCompleted

Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation

Role: lead

NCT05036369Not ApplicableCompleted

Vibrant Capsule vs. Placebo for Patient Suffering From Constipation

Role: lead

NCT03031301Not ApplicableCompleted

A Study to Assess the Efficacy and Safety of the Vibrant Capsule Administered 5 Times Per Week

Role: lead

NCT03329027Not ApplicableCompleted

A Pilot Study to Assess the Efficacy and Safety of Various Vibrating Capsule Modes

Role: lead

NCT04458675Phase 4Completed

Efficacy and Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of Chronic Idiopathic Constipation (CIC)

Role: lead

NCT02829047Not ApplicableTerminated

Tolerability, Safety and Efficacy of a New Frequency of Vibrant Capsule Administration

Role: lead

NCT02030756Not ApplicableCompleted

Performance, Efficacy and Safety of Vibrating Capsule in Aiding Constipated Individuals

Role: lead

NCT02895516Phase 2Withdrawn

Ease of Use, Tolerability, Efficacy and Safety of the Vibrant Capsule Administered in the Home Environment

Role: lead

NCT01306448Not ApplicableCompleted

Safety Evaluation of the Vibrating Capsule

Role: lead

All 10 trials loaded